Asset Center

Unbiased Selectivity Profiling with CETSA® and Mass Spectrometry
Unbiased Selectivity Profiling: Revealing True Compound Specificity and Off-Target Interactions...

Employing CETSA® in Primary Screening for p53 Binders
CETSA p53 Screening: Uncovering Potential Cancer Therapeutics Targeting p53, a key tumor suppre...

Enhancing Degrader Research with CETSA®
Unlocking New Insights into Targeted Protein Degradation with CETSA: Revealing Both Target Enga...

Dissecting the Biology of Mutant p53 with CETSA®
Unlocking the Complex Biology of Mutant p53 with CETSA: Revealing Target Engagement and Stabili...

Enhancing Primary Screening with CETSA: A Case Study in CDK4 Hit Identification
Whether exploring challenging targets or optimizing your screening approach, this poster illust...

How CETSA® Enhances Translational Studies – A Sitryx Case Study
Bridging the Gap Between In Vitro and In Vivo Drug Discovery Translating early-stage drug...

Is Your Hit on Target?
Validate Early with CETSA® Accelerate hit confirmation and lead optimization with CETSA® ...

The Power of Proteome-wide CETSA®
Uncover Drug Mechanisms with Confidence Unlock deeper insights into drug mechanisms with ...

Our Services

Uncovering Novel Modulators of PLCγ2 in Alzheimer’s Research with CETSA®
We are pleased to present our on-demand webinar, “How CETSA® has been applied in Lead Gen...

Fungal Genomes in Drug Discovery: Application of CETSA® to Study the Mechanism of Action of Brefeldin A
In this webinar, you will find the details of the project where CETSA® Explore was leveraged to...

Selectivity Profiling Brochure

Label-free validation of protein degraders using CETSA®
In this webinar, you will learn how Pelago Bioscience can support the early stages of hit ident...

Right tools, right time:
Boost your drug discovery success by adopting proteome-wide CETSA® profiling earlier  ...

CETSA: Your Key to Biological Relevance
Unlock Deeper Insights in Drug Discovery with CETSA Discover how to accelerate your drug ...

Is Your Compound Actually Therapeutic?
Translatable Insights with CETSA® Translatable Insights with CETSA® on CDK4 and RIPK...